[Federal Register: December 1, 2006 (Volume 71, Number 231)]
[Notices]               
[Page 69593]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de06-114]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 20, 2006, Organix 
Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of Cocaine (9041), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture a chemical that is a derivative of 
cocaine that will be sold to their customer for research purposes.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than January 30, 2007.

     Dated: November 21, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-20332 Filed 11-30-06; 8:45 am]

BILLING CODE 4410-09-P